These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 9846110)
1. [Diagnostic and prognostic value of interleukin-6 in malignant non-Hodgkin's lymphomas]. Serebriakov NB; Novik AA; Shamanskiĭ SV; Krivolapov IuA; Voloshin SV; D'iakova VV; Snetkova IG; Katkova IV; Zhiburt EB Vestn Ross Akad Med Nauk; 1998; (10):32-6. PubMed ID: 9846110 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of some biochemical markers as prognostic factors in malignant lymphomas. Salem HA; Eissa LA; Rabbie AM; El-Helw LM; El-Gayar AM Pak J Pharm Sci; 2006 Jul; 19(3):219-30. PubMed ID: 16935830 [TBL] [Abstract][Full Text] [Related]
4. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
5. C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Legouffe E; Rodriguez C; Picot MC; Richard B; Klein B; Rossi JF; Commes T Leuk Lymphoma; 1998 Oct; 31(3-4):351-7. PubMed ID: 9869199 [TBL] [Abstract][Full Text] [Related]
6. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Urquhart A; Berg R Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605 [TBL] [Abstract][Full Text] [Related]
7. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value. Uskudar Teke H; Gulbas Z; Bal C J BUON; 2014; 19(1):191-7. PubMed ID: 24659663 [TBL] [Abstract][Full Text] [Related]
9. Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients. Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Shono Y; Morioka M; Kawamura T; Masauzi N; Kakinoki Y; Kobayashi H; Kunieda Y; Kasai M; Kurosawa M; Asaka M; Imamura M Eur J Haematol; 2006 Nov; 77(5):403-9. PubMed ID: 16930137 [TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blay JY; Burdin N; Rousset F; Lenoir G; Biron P; Philip T; Banchereau J; Favrot MC Blood; 1993 Oct; 82(7):2169-74. PubMed ID: 8400266 [TBL] [Abstract][Full Text] [Related]
11. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas. Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567 [TBL] [Abstract][Full Text] [Related]
12. B cell non-Hodgkin's lymphoma: experience from a tertiary care cancer center. Prakash G; Sharma A; Raina V; Kumar L; Sharma MC; Mohanti BK Ann Hematol; 2012 Oct; 91(10):1603-11. PubMed ID: 22584851 [TBL] [Abstract][Full Text] [Related]
13. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197 [TBL] [Abstract][Full Text] [Related]
14. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H; Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465 [TBL] [Abstract][Full Text] [Related]
15. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma]. Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718 [TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases. Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment. Passam FH; Sfiridaki A; Pappa C; Kyriakou D; Petreli E; Roussou PA; Alexandrakis MG Int J Lab Hematol; 2008 Feb; 30(1):17-25. PubMed ID: 18190463 [TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma]. Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560 [TBL] [Abstract][Full Text] [Related]
19. CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL). Talaat RM; Abdel-Aziz AM; El-Maadawy EA; Abdel-Bary N Immunol Invest; 2015; 44(3):265-78. PubMed ID: 25564959 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological analysis of primary intestinal non-Hodgkin's lymphoma: a report of 32 cases]. Yang D; Bai CM; Xiao Y; Chen J Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):445-8. PubMed ID: 15498216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]